24 May 2013
Keywords: altana, moving, roflumilast, into, ph, iii, german
Article | 17 August 2001
German drugmaker Altana AG says that its novel asthma therapyroflumilast is about to move into Phase III trials, which led ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 August 2001
16 August 2001
23 May 2013
© 2013 thepharmaletter.com